OPEN END TURBO OPTIONSSCHEIN LONG - AMGEN | Market Closed - BOERSE MUENCHEN 19:25:16 28/06/2024 BST | ||
| 6.71 EUR | +0.30% |
|
| Current month | +11.28% | ||
| 1 month | +20.04% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 6.71 | +0.30% |
| 27/06/24 | 6.69 | -2.34% |
| 26/06/24 | 6.85 | -8.42% |
| 25/06/24 | 7.48 | +5.65% |
| 24/06/24 | 7.08 | +8.42% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 07:25 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GP94WS |
| ISIN | DE000GP94WS9 |
| Date issued | 18/07/2023 |
| Strike | 240.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.32 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.6 € |
|---|---|
| Lowest since issue | 0.719 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
